| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |